Evaluation of infant methylenetetrahydrofolate reductase genotype, maternal vitamin use, and risk of high versus low level spina bifida defects

Birth Defects Research Part A - Clinical and Molecular Teratology

Volumn 67, Issue 3, 2003, Pages 154-157

  Volcik, Kelly A ^a   Shaw, Gary M ^b   Lammer, Edward J ^c   Zhu, Huiping ^a   Finnell, Richard H ^a  

^a TEXAS A AND M HEALTH SCIENCE CENTER   (United States)

^b California Birth Defects Monitoring Program   (United States)

^c CHILDREN S HOSPITAL OAKLAND   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); FOLIC ACID; GENOMIC DNA;

ARTICLE; BLOOD SAMPLING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DNA DETERMINATION; DNA EXTRACTION; DRUG USE; ENZYME ACTIVITY; GENETIC ASSOCIATION; GENETIC RISK; GENOTYPE; HOMOZYGOTE; HUMAN; MAJOR CLINICAL STUDY; NEWBORN; NEWBORN SCREENING; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RESTRICTION MAPPING; RISK ASSESSMENT; RISK FACTOR; SPINA BIFIDA; UNITED STATES;

CALIFORNIA; CASE-CONTROL STUDIES; DIETARY SUPPLEMENTS; DNA; FEMALE; FOLIC ACID; GENETIC PREDISPOSITION TO DISEASE; GENOME, HUMAN; GENOTYPE; HUMANS; INFANT, NEWBORN; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); ODDS RATIO; OXIDOREDUCTASES ACTING ON CH-NH GROUP DONORS; POLYMERASE CHAIN REACTION; PREGNANCY; RISK; SPINAL DYSRAPHISM;

EID: 0141925974     PISSN: 15420752     EISSN: None     Source Type: Journal    
DOI: 10.1002/bdra.10008     Document Type: Article

References (23)

1. Croen LA, Shaw GM, Jensvold NG, Harris JA. 1991. Birth defects monitoring in California: a resource for epidemiological research. Paediatr Perinat Epidemiol 5:423-427.
2. Czeizel AE, Dudas I. 1992. Prevention of the first occurrence of neural tube defects by periconceptional vitamin supplementation. N Engl J Med 327:1832-1835.
3. Edmonds LD, James LM. 1990. Temporal trends in the prevalence of congenital malformations at birth based on the Birth Defects Monitoring Program, United States, 1979-1987. MMWR CDC Surveill Summ 39:19-23.
4. Franco RF, Araujo AG, Guerreiro JF, Elion J, Zago MA. 1998. Analysis of the C677T mutation of the methylenetetrahydrofolate reductase gene in different ethnic groups. Thromb Haemost 79:119-121.
5. Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Matthews RG, Boers GJ, den Heijer M, Kluijtmans LA, van den Heuvel LP, et al. 1995. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 10:111-113.
6. Goyette P, Christensen B, Rosenblatt DS, Rozen R. 1996. Severe and mild mutations in cis for the methylenetetrahydrofolate reductase (MTHFR) gene, and description of five novel mutations in MTHFR. Am J Hum Genet 59:1268-1275.
7. Goyette P, Sumner JS, Milos R, Duncan AMV, Rosenblatt DS, Matthews RG, Rozen R. 1994. Human methylenetetrahydrofolate reductase: isolation of cDNA, mapping and mutation identification. Nat Genet 7:195-200.
8. Kang S-S, Wong PWK, Susmano A, Sora J, Norusis M, Ruggie N. 1991. Thermolabile methylenetetrahydrofolate reductase: an inherited risk factor for coronary disease. Am J Hum Genet 48:536-545.
9. Langman LJ, Cole DEC. 1999. Homocysteine. Crit Rev Clin Lab Sci 36:365-406.
10. MRC Vitamin Study Research Group. 1991. Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. Lancet 338:131-137.
11. Ou CY, Stevenson RE, Brown VK, Schwartz CE, Allen WP, Khoury MJ, Rozen R, Oakley GP, Adams MJ. 1996. 5,10-Methylenetetrahydrofolate reductase genetic polymorphism as a risk factor for neural tube defects. Am J Med Genet 63:610-614.
12. Schwartz EI, Khalchitsky SE, Eisensmith RC, Woo SL. 1990. Polymerase chain reaction amplification from dried blood spots on Guthrie cards. Lancet 336:639-640.
13. Shaw GM, Rozen R, Finnell RH, Wasserman CR, Lammer EJ. 1998. Maternal vitamin use, genetic variation of infant methylenetetrahydrofolate reductase, and risk for spina bifida. Am J Epidemiol 148:30-37.
14. Shaw GM, Schaffer D, Velie EM, Morland K, Harris JA. 1995. Periconceptional vitamin use, dietary folate, and the occurrence of neural tube defects. Epidemiology 6:219-226.
15. Steegers-Theunissen RPM, Boers GHJ, Trijbels FJM, Eskes TKAB. 1991. Neural-tube defects and derangement of homocysteine metabolism. N Engl J Med 324:199-200.
16. Steegers-Theunissen RP, Boers GH, Trijbels FJ, Finkelstein JD, Blom HJ, Thomas CM, Borm GF, Wouters MG, Eskes TK. 1994. Maternal hyperhomocysteinemia: a risk factor for neural-tube defects? Metabolism 43:1475-1480.
17. Van Allen MI, Kalousek DK, Chernoff GF, Juriloff D, Harris M, McGillivray BC, Yong SL, Langlois S, MacLeod PM, Chitayat D, Friedman JM, Wilson RD, McFadden D, Pantzar J, Ritchie S, Hall JG. 1993. Evidence for multi-site closure of the neural tube in humans. Am J Med Genet 47:723-743.
18. van der Put NM, Steegers-Theunissen RP, Frosst P, Trijbels FJ, Eskes TK, Van Den Huevel LP, Mariman EC, Den Heyer M, Rozen R, Blom HJ. 1995. Mutated methylenetetrahydrofolate reductase as a risk factor for spina bifida. Lancet 346:1070-1071.
19. van der Put NM, Thomas CM, Eskes TK, Trijbels FJ, Steegers-Theunissen RP, Mariman EC, Graaf-Hess A, Smeitink JA, Blom HJ. 1997. Altered folate and vitamin B12 metabolism in families with spina bifida offspring. QJM 90:505-510.
20. Volcik KA, Blanton SH, Tyerman GH, Jong ST, Rott EJ, Page TZ, Romaine NK, Northrup H. 2000. Methylenetetrahydrofolate reductase and spina bifida: evaluation of level of defect and maternal genotypic risk in Hispanics. Am J Med Genet 95:21-27.
21. Wasserman CR, Shaw GM, O'Malley CD, Tolarova MM, Lammer EJ. 1996. Parental cigarette smoking and risk for congenital anomalies of the heart, neural tube, or limb. Teratology 53:261-267.
22. Wenstrom KD, Johanning GL, Owen J, Johnston KE, Acton S, Cliver S, Tamura T. 2000. Amniotic fluid homocysteine levels, 5,10-methylenetetrahydrofolate reductase genotypes, and neural tube closure sites. Am J Med Genet 90:6-11.
23. Wilcken DEL. 1997. MTHFR C677T mutation, folate intake, neural-tube defect, and risk of cardiovascular disease. Lancet 350:603-604.